Lv61
1750 积分 2024-10-16 加入
Esophageal Cancer
12天前
已完结
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
1个月前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
1个月前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
1个月前
已完结
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
2个月前
已完结
European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’
3个月前
已完结
Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme
3个月前
已完结
皖公网安备34019202002308
